Skip to main content
. 2020 Jul 13;77(11):1–9. doi: 10.1001/jamaneurol.2020.2273

Table 1. Hedges g and SEs for Studies and Selected Individual- and Study-Level Variables.

Source No. of patients at baseline Age at baseline, y Sex (male vs female), % Delirium at baseline, % Duration of follow-up, y No. of covariates Matching/adjustment at baseline Attrition rate, % g (SE)
Bickel et al,12 2008 180 73.8 31 23 3.2 4 Yes 9 2.04 (0.63)
Brown et al,13 2018 143 70 75 54 1.0 5 Yes 24 0.18 (0.17)
Davis et al,14 2012 558 88.3 20 13 10.0 3 Yes 1 1.05 (0.13)
Davis et al,15 2017 987 90a 31 28 5.2 4 Yes 0 0.22 (0.07)
Franck et al,16 2016 720 70 54 21 0.3 8 Yes 23 0.52 (0.25)
Fong et al,17 2009 408 73.9 43 18 1.4 8 Yes 0 0.47 (0.13)
Fong et al,18 2012 771 77.2 43 53 2.0 10 Yes 23 0.38 (0.13)
Girard et al,19 2018 964 62 60 69 1.0 8 Yes 35 0.15 (0.07)
Gross et al,20 2012 263 78.3 43 56 3.2 8 Yes 69 0.45 (0.13)
Inouye et al,21 2016 560 76.7 42 24 3.0 10 Yes 44 0.23 (0.1)
Kat et al,22 2008 112 82.7 NA 63 2.5 4 Yes 56 0.63 (0.2)
Krogseth et al,23 2016 287 85.7 26 70 0.4 1 Yes 30 0.33 (0.13)
Lingehall et al,24 2017 114 76.5 69 53 5.0 13 Yes 6 0.75 (0.19)
Lundström et al,25 2003 67 79.1 23 28 5.0 3 Yes 40 0.94 (0.4)
Mitchell et al,26 2018 148 57 69 19 0.5 9 No 47 0.12 (0.21)
Neerland et al,27 2017 387 84.5 24 32 0.8 4 Yes 31 1.05 (0.3)
Pandharipande et al,28 2013 821 61 51 75 1.0 9 Yes 43 0.5 (0.03)
Rockwood et al,29 1999 203 79 43 19 3.0 3 Yes 50 0.98 (0.33)
Rudolph et al,30 2008 1161 68.7 53 9 0.3 3 No 19 0.14 (0.19)
Saczynski et al,31 2012 225 73 76 46 1.0 8 Yes 0 0.26 (0.13)
Sauër et al,32 2017 184 67.1 72 13 1.0 3 Yes 21 0.67 (0.08)
Sprung et al,33 2017 1667 80 53 2 0.8 5 Yes 31 0.61 (0.28)
Vasunilashorn et al,34 2018 560 76.7 42 56 3.0 9 Yes 11 0.25 (0.09)
Wacker et al,35 2006 29 77.1 34 48 NA 0 No 0 1.03 (0.39)

Abbreviation: NA, not applicable.

a

Mean age at baseline.